Open Medicine Foundation®
Leading research. Delivering hope.
ME/CFS and related chronic complex diseases

Magnetic Levitation Platform

TECHNOLOGY VALUE

Demonstrates a significant difference between ME/CFS patients and healthy controls.

LEAD INVESTIGATORS
  • Julie Wilhelmy, PhD

  • Ronald W. Davis, PhD

UPDATES AND POTENTIAL
 

TECHNOLOGY DESCRIPTION

Julie Wilhelmy, SGTC

Developed by Julie Wilhelmy, PhD, in collaboration with Ronald W. Davis, PhD, at Stanford University.

The Seahorse instrument measures oxygen during energy production processes that occur in the mitochondria. A protocol using the Seahorse has revealed a significant difference between activated T-cells of ME/CFS patients and healthy controls.

The instrument is commercially available, which will allow other laboratories to easily reproduce the results.

 

 

Stay Informed

Be the first to hear our research news.

Subscribe Now.

No thanks
Donate